1. Home
  2. NNY vs TLSA Comparison

NNY vs TLSA Comparison

Compare NNY & TLSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Nuveen New York Municipal Value Fund

NNY

Nuveen New York Municipal Value Fund

HOLD

Current Price

$8.66

Market Cap

161.7M

Sector

Finance

ML Signal

HOLD

Logo Tiziana Life Sciences Ltd.

TLSA

Tiziana Life Sciences Ltd.

HOLD

Current Price

$1.42

Market Cap

192.1M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
NNY
TLSA
Founded
1987
2013
Country
United States
United Kingdom
Employees
N/A
N/A
Industry
Investment Managers
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
161.7M
192.1M
IPO Year
N/A
2017

Fundamental Metrics

Financial Performance
Metric
NNY
TLSA
Price
$8.66
$1.42
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
43.1K
130.9K
Earning Date
01-01-0001
01-01-0001
Dividend Yield
4.04%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
N/A
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$7.77
$0.73
52 Week High
$8.94
$2.60

Technical Indicators

Market Signals
Indicator
NNY
TLSA
Relative Strength Index (RSI) 53.88 49.44
Support Level $8.30 $1.29
Resistance Level $8.83 $1.65
Average True Range (ATR) 0.15 0.10
MACD 0.01 0.02
Stochastic Oscillator 55.26 61.11

Price Performance

Historical Comparison
NNY
TLSA

About NNY Nuveen New York Municipal Value Fund

Nuveen New York Municipal Value Fund Inc. is a diversified closed-end management investment company. The Fund seeks to provide current income exempt from regular federal, New York State, and New York City income taxes, and from the federal alternative minimum tax for individuals, while enhancing portfolio value relative to the municipal bond market by investing in tax-exempt municipal bonds considered underrated, undervalued, or from undervalued municipal market sectors. It may invest in municipal securities such as lease obligations and certificates of participation, which provide an undivided interest in pools of municipal leases or installment purchase agreements.

About TLSA Tiziana Life Sciences Ltd.

Tiziana Life Sciences Ltd is a clinical-stage biotechnology company that specializes in developing transformative therapies for neurodegenerative and neuroinflammatory diseases. Its clinical pipeline includes drug assets for Secondary Progressive Multiple Sclerosis, ALS. Alzheimer's, Crohn's Disease, and KRAS+ NSCLC. Tiziana is led by a team of qualified executives with extensive drug development and commercialization experience.

Share on Social Networks: